Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery
1 other identifier
observational
154
1 country
1
Brief Summary
In this project, the investigators aim to compare the safety, efficacy, and predictability outcomes of conventional CEIOL surgery to Femtosecond-laser-assisted CEIOL (FLACS) in an effort to improve cataract surgery outcomes. The investigators hypothesis is that FLACS may lead to preservation of endothelial cells compared to conventional CE IOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2014
CompletedFirst Posted
Study publicly available on registry
March 26, 2014
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedNovember 16, 2018
November 1, 2018
4.5 years
March 16, 2014
November 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
endothelial cell density three months after conventional CEIOL or FLACS compared to baseline
endothelial cell density will be compared at baseline and three months after a patient undergoes FLACS or Conventional CE IOL to see which technique causes less endothelial cell loss.
up to 2 years
Study Arms (2)
conventional
Patients who undergo routine cataract surgery using conventional phacoemulsification technique
FLACS
Patients who undergo femtosecond laser assisted cataract surgery
Eligibility Criteria
Patients who present to our center with visually significant cataract and who may benefit from cataract surgery
You may qualify if:
- Patients older than 18 years of age
- Ability to understand and sign an informed consent
- Visually significant cataract eligible to undergo cataract extraction by phacoemulsification with primary intraocular lens implantation in at least 1 eye
- Ability and commitment to follow up for 18 months after surgery
- No other ocular pathology and no previous/concurrent surgery
You may not qualify if:
- Any other ocular pathology that may affect best-corrected visual acuity
- Previous or concurrent ocular surgery
- Subjects who are pregnant, lactating, or planning to be pregnant during the course of the study.
- Patients with keratoconus or keratectasia
- Patients who are blind on one eye
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins University
Baltimore, Maryland, 21044, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yassine daoud, md
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2014
First Posted
March 26, 2014
Study Start
May 1, 2014
Primary Completion
November 1, 2018
Study Completion
November 1, 2018
Last Updated
November 16, 2018
Record last verified: 2018-11